Chemed Corp: Form 10-K for the period ended Dec 31, 2019
Filed with the SEC on Feb 26, 2020 and accepted by EDGAR at Feb 26, 2020, 14:20 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2019-01-01 to 2019-12-31 | $1.28bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2019-01-01 to 2019-12-31 | $1.32bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 12 months2019-01-01 to 2019-12-31 | $305.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2019-01-01 to 2019-12-31 | $257.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2019-01-01 to 2019-12-31 | $4.5m | us-gaap:InterestExpense |
| Income tax | 12 months2019-01-01 to 2019-12-31 | $41.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2019-01-01 to 2019-12-31 | $219.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2019-01-01 to 2019-12-31 | $13.31 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2019-01-01 to 2019-12-31 | $13.77 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2019-01-01 to 2019-12-31 | 16,527,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2019-01-01 to 2019-12-31 | $301.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2019-01-01 to 2019-12-31 | $53.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2019-01-01 to 2019-12-31 | $19.8m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2019-01-01 to 2019-12-31 | $92.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-12-31 | $6.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-12-31 | $190.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2019-12-31 | $1.27bn | us-gaap:Assets |
| Current liabilities | At period end2019-12-31 | $262.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-12-31 | $541.7m | us-gaap:Liabilities |
| Long-term debt | At period end2019-12-31 | $90.0m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2019-12-31 | $726.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000019584-20-000006. Last ingested by Listed: Nov 5, 2026, 15:55 ET. Listed shows no prices and gives no investment advice.